New Zealand markets closed

Altimmune, Inc. (ALT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.01-0.89 (-10.00%)
At close: 04:00PM EDT
8.00 -0.01 (-0.12%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 567.93M
Enterprise value 386.45M
Trailing P/E 1.82
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.14k
Price/book (mrq)3.28
Enterprise value/revenue 942.57
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.20
52-week change 378.79%
S&P500 52-week change 326.49%
52-week high 314.84
52-week low 32.09
50-day moving average 38.33
200-day moving average 36.33

Share statistics

Avg vol (3-month) 34.36M
Avg vol (10-day) 33.34M
Shares outstanding 570.9M
Implied shares outstanding 670.9M
Float 870.34M
% held by insiders 10.78%
% held by institutions 162.91%
Shares short (30 Apr 2024) 422.31M
Short ratio (30 Apr 2024) 47.15
Short % of float (30 Apr 2024) 431.71%
Short % of shares outstanding (30 Apr 2024) 431.46%
Shares short (prior month 28 Mar 2024) 417.73M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 314 Sept 2018
Ex-dividend date 420 Jan 2017
Last split factor 21:30
Last split date 314 Sept 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-535,879.98%

Management effectiveness

Return on assets (ttm)-29.48%
Return on equity (ttm)-54.46%

Income statement

Revenue (ttm)410k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-76.20%
Gross profit (ttm)N/A
EBITDA -88.09M
Net income avi to common (ttm)-92.77M
Diluted EPS (ttm)-1.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)182.02M
Total cash per share (mrq)2.57
Total debt (mrq)552k
Total debt/equity (mrq)0.32%
Current ratio (mrq)16.55
Book value per share (mrq)2.44

Cash flow statement

Operating cash flow (ttm)-72.76M
Levered free cash flow (ttm)-45.06M